Meghana Keshavan

Meghana Keshavan

Meghana has spent the last year-and-a-half writing about biotech and healthcare for the San Diego Business Journal. Previously, she's worked for Reuters, Crain’s Detroit Business, the Detroit Free Press and WDET, a Detroit-based National Public Radio affiliate. Meghana studied biochemistry and molecular biology at Penn State University and spent five years as a self-described "research peon in a schizophrenia genetics lab."

Follow Meghana Keshavan: Twitter |


New legs for a fluorescent tech that helps measure apoptosis

New legs for a fluorescent tech that helps measure apoptosis

October 22, 2014 6:40 pm by | 0 Comments

Learning how apoptosis works – that is, the programmed death of a cell - could play an important role in helping researchers understand how debilitating diseases work – or even how to make drugs…


Nerd alert: How the mazes of Dungeons & Dragons and pharma R&D compare

Nerd alert: How the mazes of Dungeons & Dragons and pharma R&D compare

October 22, 2014 1:42 pm by | 0 Comments

The pharma industry just got a hell of a lot nerdier, thanks to a recent Forbes op-ed. It likens the maze-like research and development quagmire to the elf-infused quests seen in fantasy role-playing game Dungeons and Dragons….



A breathalyzer for hospital-acquired infection

A breathalyzer for hospital-acquired infection

October 22, 2014 6:00 am by | 0 Comments

Wisconsin startup Isomark has developed a breath-based test that can detect infection within two hours of its onset. The patented concept has wide-reaching applications – for instance, it’s proposed developing a…


Wow of the Week: A breathalyzer and video game to help smokers quit the cigs

Wow of the Week: A breathalyzer and video game to help smokers quit the cigs

October 18, 2014 8:30 am by | 0 Comments

A weapon of ash destruction. That’s what New York startup IntelliQuit‘s calling its new smoking cessation system – a nicotine breathalyzer that comes coupled with a couple of video games…


Funding Roundup: Which biotech, medtech and healthIT startups got investments this week?

Funding Roundup: Which biotech, medtech and healthIT startups got investments this week?

October 17, 2014 4:14 pm by | 0 Comments

Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you - based on regulatory filings reported…


How dangerous IS that infectious disease? This infograph tells you

How dangerous IS that infectious disease? This infograph tells you

October 17, 2014 10:52 am by | 0 Comments

London-based data journalist David McCandless put together a pretty scatterplot about the relative dangers of infectious disease.  McCandless sums up the infograph nice: “It’s a statistical measure of how likely an…


Hey, medical device startups: You should probably apply today for the MedTech Innovator pitchfest.

Hey, medical device startups: You should probably apply today for the MedTech Innovator pitchfest.

October 17, 2014 6:00 am by | 0 Comments

Just a friendly heads up: Today’s the last day to apply for next month’s MedTech Innovator competition – a pitchfest for the early stage medical device set. Ten semi-finalists will be…



Venture firm Canaan Partners raises $675 million more; plans to invest in healthcare, tech startups

Venture firm Canaan Partners raises $675 million more; plans to invest in healthcare, tech startups

October 16, 2014 12:00 pm by | 0 Comments

Menlo Park venture firm Canaan Partners just raised $675 million for its tenth fund – with plans to invest this Fund X mostly in early stage and seed stage startups…


Twitter “astroturfing” undermining public health initiatives? Say it ain’t so!

Twitter “astroturfing” undermining public health initiatives? Say it ain’t so!

October 16, 2014 11:30 am by | 77 Comments

No one’s safe from the “Twitter bomb” – not even a public health campaign. The Chicago Department of Public Health was subject to some serious astroturfing earlier this year, a…


It’s all about consolidation these days – in pharma, medtech and biotech M&A

It’s all about consolidation these days – in pharma, medtech and biotech M&A

October 16, 2014 9:59 am by | 0 Comments

This year’s been a big deal for big deals in pharma, biotech and medtech: There have been 869 deals worth $354.3 billion, according to a new Mergermarket report – the…


Imaging backup for the standard mammogram meant to improve breast cancer screenings

Imaging backup for the standard mammogram meant to improve breast cancer screenings

October 15, 2014 5:33 pm by | 0 Comments

A breast cancer diagnostics startup that offers an ancillary imaging system to use on top of standard mammography just raised $6.5 million, according to regulatory filings. New Hampshire-based Gamma Medica has developed…


Selecta raises $20M for diabetes and gout immunotherapies

Selecta raises $20M for diabetes and gout immunotherapies

October 15, 2014 12:52 pm by | 0 Comments

With support from Sanofi and the Juvenile Diabetes Research Foundation, Boston-based Selecta Biosciences has raised $20 million to advance drug candidates for Type 1 diabetes and severe gout. Of the gout program,…


Herpes vaccine maker Genocea reports positive results a year after the first dose

Herpes vaccine maker Genocea reports positive results a year after the first dose

October 15, 2014 6:00 am by | 1 Comments

Cambridge pharmaceutical maker Genocea remains at the head of the herpes vaccine pack, having newly released another set of positive results for its experimental HSV2 vaccine. The company has found that its herpes…


Researchers crowdfunding to help fund Ebola sample analysis

Researchers crowdfunding to help fund Ebola sample analysis

October 14, 2014 3:37 pm by | 0 Comments

Researcher Erica Ollmann Saphire is getting sent Ebola samples faster than she can process them at her Scripps Research Institute lab, the San Diego Union-Tribune reports, so she’s turned to crowdfunding…


Syncardia ramping up production of its total artificial heart

Syncardia ramping up production of its total artificial heart

October 14, 2014 2:29 pm by | 1 Comments

To keep up with the demand for its total artificial heart, Tucson-based Syncardia is in the midst of a Series F funding round, a spokesman said. This isn’t new technology….